Impact of the COVID-19 Pandemic on Inpatient Antibiotic Consumption in Switzerland.

Bibliographic Details
Title: Impact of the COVID-19 Pandemic on Inpatient Antibiotic Consumption in Switzerland.
Authors: Friedli, Olivier, Gasser, Michael, Cusini, Alexia, Fulchini, Rosamaria, Vuichard-Gysin, Danielle, Halder Tobler, Roswitha, Wassilew, Nasstasja, Plüss-Suard, Catherine, Kronenberg, Andreas
Source: Antibiotics (2079-6382); Jun2022, Vol. 11 Issue 6, p792, 12p
Subject Terms: COVID-19 pandemic, ANTIBIOTICS, COVID-19, CONSUMPTION (Economics), HOSPITAL patients
Geographic Terms: SWITZERLAND
Abstract: The aim of this study was to analyze inpatient antibiotic consumption during the first 16 months of the COVID-19 pandemic in Switzerland. The entire period (January 2018–June 2021) was divided into the prepandemic period, the first and second waves, and the intermediate period. In the first year of the pandemic, total overall inpatient antibiotic consumption measured in defined daily doses (DDD) per 100 bed-days remained stable (+1.7%), with a slight increase in ICUs of +4.2%. The increase in consumption of broad-spectrum antibiotics was +12.3% overall and 17.3% in ICUs. The segmented regression model of monthly data revealed an increase in overall antibiotic consumption during the first wave but not during the second wave. In the correlation analysis performed in a subset of the data, a significant positive association was found between broad-spectrum antibiotic consumption and an increasing number of hospitalized COVID-19 patients (p = 0.018). Restricting this dataset to ICUs, we found significant positive correlations between the number of hospitalized COVID-19 patients and total antibiotic consumption (p = 0.007) and broad-spectrum antibiotic consumption (p < 0.001). In conclusion, inpatient antibiotic use during the different periods of the COVID-19 pandemic varied greatly and was predominantly notable for broad-spectrum antibiotics. [ABSTRACT FROM AUTHOR]
Copyright of Antibiotics (2079-6382) is the property of MDPI and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database: Complementary Index
More Details
ISSN:20796382
DOI:10.3390/antibiotics11060792
Published in:Antibiotics (2079-6382)
Language:English